Simon C. Johnson, Ph.D.
Affiliations: | 2013 | Pathology | University of Washington, Seattle, Seattle, WA |
Area:
Aging, Molecular Biology, PathologyGoogle:
"Simon Johnson"Parents
Sign in to add mentor| Peter S. Rabinovitch | grad student | 2013 | University of Washington | |
| (Growth Signaling in Aging and Disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bornstein R, Mulholland MT, Sedensky M, et al. (2023) Glutamine metabolism in diseases associated with mitochondrial dysfunction. Molecular and Cellular Neurosciences. 126: 103887 |
| Hanaford A, Johnson SC. (2022) The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence. Orphanet Journal of Rare Diseases. 17: 335 |
| Gonzalez B, Tare A, Ryu S, et al. (2022) High-throughput sequencing analysis of nuclear-encoded mitochondrial genes reveals a genetic signature of human longevity. Geroscience |
| Bornstein R, James K, Stokes J, et al. (2021) Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy. Neurobiology of Disease. 105594 |
| Bornstein R, Gonzalez B, Johnson SC. (2020) Mitochondrial pathways in human health and aging. Mitochondrion |
| Johnson SC, Kayser EB, Bornstein R, et al. (2020) Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease. Molecular Genetics and Metabolism |
| Kahn-Kirby AH, Amagata A, Maeder CI, et al. (2019) Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy. Plos One. 14: e0214250 |
| Johnson SC. (2018) Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease. Sub-Cellular Biochemistry. 90: 49-97 |
| Johnson SC, Pan A, Li L, et al. (2018) Neurotoxicity of anesthetics: Mechanisms and meaning from mouse intervention studies. Neurotoxicology and Teratology |
| Johnson SC, Martinez F, Bitto A, et al. (2018) mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases. Kidney International |